Mateon and PointR to merge into AI-driven oncology firm
FinData: Share Price for NASDAQ, MATN - Mateon Therapeutics Inc.
iBio Announces Collaboration with EdgePoint AI for Next Gen Biologics Manufacturing - DATAVERSITY
Mateon | HealthWire
Mateon Completes Its Acquisition of PointR Data Inc. - DATAVERSITY
Mateon Therapeutics
MATN: Positive Early Results for ARTIVeda™ in Treating COVID-19…
Mateon Therapeutics - BIO Investor Forum | BIO
Windlas Biotech, Mateon Therapeutics bring lung therapy food supplement PulmoHeal - FFOODS Spectrum - Unleashing the Power of Food Science & Technology
Windlas Biotech and Mateon Therapeutics Launch India's First Combined Lung Therapy and Ai Telemedicine 360 Solution to Transform Respiratory Wellness - The Pharma Times | Pharma & Health Care News Portal
COVID Pandemic Hastens Search For New Technology And CRO Partner
Windlas Biotech, Mateon Therapeutics launch drug-device plus lung therapy platform - Express Pharma
Mateon Therapeutics
Blockchain-Fueled Company Mateon Develops Phase 3 Clinical Drug Candidate, Against COVID-19 - OT-101 – Blockchain News, Opinion, TV and Jobs
Zacks Small-Cap Research
A Covid-19 treatment plan slowly emerges | Evaluate
DEVELOPMENT UPDATE FOR ARTIVEDA™/ARTISHIELD™ AGAINST
Mateon Halts Lead Candidate Development, Axes 60% of Workforce
Mateon Therapeutics completes acquisition of PointR Data
Dr. Anthony E. Maida will be presenting at the Marcus Evans Evolution Summit
Consulting Agreement by and between the Company and Artius, | MATEON THERAPEUTICS INC | Business Contracts | Justia
Keeping an eye on Mateon Therapeutics (OTCQB: MATN) says GEN - Genetic Engineering & Biotechnology News - EmergingGrowth.com
Joint Venture Agreement relating to GMP Biotechnology Limited | MATEON THERAPEUTICS INC | Business Contracts | Justia
NantCell Binding Termsheet | MATEON THERAPEUTICS INC | Business Contracts | Justia
